EUP OHAMR: Joint Transnational Call 2026

This is the first European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) joint transnational call for projects to explore new treatments to tackle antimicrobial resistance (AMR). The aim is to improve the treatment success rates of patients, animals, and plants affected by bacterial or fungal infections by providing new treatment options.

Research and innovation proposals submitted under this call must address one of the following topics:

• Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobials with adjunctive treatments to extend drug efficacy and combat resistance.

• Topic 2: Develop tools and methods to improve adherence to treatment protocols.

• Topic 3: Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use.

The following requirements apply for all call topics:

• Proposals should consider how the proposed approach will impact the risk of resistance in other One Health settings and could be extended to other One Health settings.

• Proposals should explain their feasibility by outlining realistic objectives, practical methodologies, and achievable timelines (e.g., workplan, risk identification, allocation of resources, capacity of the consortium to conduct the work, business plan if the proposal envisages commercial component, etc).

• Proposals must clearly demonstrate the potential health, social, and/or economic impact(s) of the expected results. In particular, the proposals should explain how the uptake of the expected project results by the society/end-users/next actors in the value chain will be facilitated.

• Proposals should clearly demonstrate the benefit of working together and the unique contribution of each partner (i.e. expertise, resources). In addition, the proposals should demonstrate the added value of transnational collaboration: sharing of expertise and resources (models, databases…), harmonisation of data, access to innovative technologies, etc.

• Participation of the private sector (startup, small and medium-sized enterprises, or SMEs, industry) in the consortium is encouraged for all call topics if appropriate and if allowed according to national funding eligibility rules.